Breaking Finance News

A report released today by B. Riley about Insulet Corporation (NASDAQ:PODD) raises the target price to $46.00

Insulet Corporation (NASDAQ:PODD) had its price target raised to $46.00 by B. Riley in a report issued 09/26/2016. The updated target price indicates a possible upside of 0.06% from the company's most recent stock price close.

Previously on 08/04/2016, Wedbush reported on Insulet Corporation (NASDAQ:PODD) bumped up the target price from $44.00 to $48.00 that suggested an upside of 0.15%.

Just yesterday Insulet Corporation (NASDAQ:PODD) traded -1.53% lower at $43.25. Insulet Corporation’s 50-day average is $43.08 and its two hundred day average is $34.76. With the last stock price up 24.46% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. Trading volume was down over the average, with 535,626 shares of PODD changing hands under the typical 560,759

Recent Performance Chart

Insulet Corporation (NASDAQ:PODD)

Insulet Corporation has with a one year low of $23.94 and a one year high of $45.60 and has a total market value of $0.

More About Insulet Corporation (NASDAQ:PODD)

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The OmniPod System consists of the OmniPod, a small, self-adhesive disposable tubeless OmniPod device, which is worn on the body for approximately three days at a time and its wireless handheld Personal Diabetes Manager (PDM). The Company purchases OmniPods pursuant to its agreement with Flextronics. It also partners with pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. It sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The Company purchases OmniPods pursuant to its agreement with Flextronics. The OmniPod System is available in Europe, Canada and Israel.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.